Finding the right dosage is a major challenge, not just with psychedelics, but any other drug. Some people try microdosing and fail to get any results. Others overdose and get bad trips. It really is a question of trial and error, but a wrong dose is the cause of many psychedelic-related problems.
Considering people are different, the effects of the dose will not be the same from one person to another. It doesn’t matter whether you are microdosing or taking very high doses, the effect and how well the drug functions varies. That’s why finding the correct psychedelic dosage matters.
Even if a substance is labelled as being a good remedy, it becomes poisonous to the body if taken incorrectly. This is to say dosage is a key factor in altering a drug’s effects. Take this as an example, imagine a person taking a shot of vodka while another takes a whole bottle of vodka. The impact will be different and they will have different experiences even though they both took vodka. The difference is in quantity. This same mechanism applies in psychedelic dosing.
Non-toxic substances, such as LSD and psilocybin, can still have negative effects on a patient’s wellbeing. If taken in abundance, it can cause ‘poisonous’ experiences.
Though set and setting are situations that may result in a bad trip, dosage is the key factor. Most studies show that taking psychedelic treatments in a noisy place, and surrounded by people can result in bad trips. What if an individual was in a different safe and quiet environment but instead took a high dosage? Will they not have a bad trip?
A Boston psychonaut, the late Kilindi Iyi, supported this notion when he stated that set and setting doesn’t matter whatsoever in situations where a patient takes high doses of magic mushrooms. This means that dosage is a vital factor in psychedelic sessions.
Before taking matters in your own hands and exploring substances, read below some practical tips.
Understandably, not everyone is designed to be meticulous and adhere to all the suggestions above, and that could explain why psychedelics companies like Eleusis Ltd. insist that these substances should only be administered in a clinical setting where professionals can supervise the entire process.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
According to a recent study, individuals who have used classic psychedelics like LSD or psilocybin…
There is a growing trend in which parents take tiny doses of psychedelics like LSD…
Walter Reed National Military Medical Center officials confirmed they are awaiting a $4.9m grant to…
A new study has found that while all ethnic and racial groups can benefit from…
A new study that is yet to be peer-reviewed has found that rats given psilocybin…
The American embassy in Peru has warned Americans against taking traditional psychedelics like the ayahuasca…